Company: STAA
Filing Date: 2025-02-21
Form Type: 10-K
Source: 0000950170-25-024813
Chunk: 180

Company: STAAR SURGICAL CO
Filing Date: 2025-02-21
Form: 10-K
Item: Item 8
Chunk 180
---
    14,594

    35,715

    Cash flows from investing activities:

    Acquisition of property and equipment

    (23,394
    )

    (18,188
    )

    (18,108
    )

    Purchase of investments available for sale

    (80,240
    )

    (52,313
    )

    (155,748
    )

    Proceeds from maturity of investments available for sale

    43,103

    143,548

    17,121

    Proceeds from sale of investments available for sale

    1,314

    1,300

    359

    Net cash provided by (used in) investing activities

    (59,217
    )

    74,347

    (156,376
    )

    Cash flows from financing activities:

    Repayment of finance lease obligations

    (165
    )

    (161
    )

    (126
    )

    Repurchase of employee common stock for taxes withheld

    (1,505
    )

    (2,097
    )

    —

    Proceeds from the exercise of stock options

    7,392

    9,672

    8,422

    Proceeds from vested restricted stock

    2

    1

    1

    Net cash provided by financing activities

    5,724

    7,415

    8,297

    Effect of exchange rate changes on cash and cash equivalents

    (1,111
    )

    202

    (862
    )

    Increase (decrease) in cash and cash equivalents

    (38,879
    )

    96,558

    (113,226
    )

    Cash and cash equivalents, at beginning of year

    183,038

    86,480

    199,706

    Cash and cash equivalents, at end of year
     
    $
    144,159

    $
    183,038

    $
    86,480

The accompanying notes are an integral part of these consolidated financial statements.

F-8

STAAR SURGICAL COMPANY AND SUBSIDIARIES